Global X Genomics & Biotechnology ETF (NQ:GNOM)

47.05 +0.73 (+1.58%)

Streaming Delayed Price Updated: 3:59 PM EST, Feb 18, 2026 Add to My Watchlist

Price and Volume

Volume	4,757
Open	46.59
Bid (Size)	46.86 (300)
Ask (Size)	47.06 (200)
Prev. Close	46.32
Today's Range	46.59 - 47.09
52wk Range	27.20 - 51.42
Shares Outstanding	33,418,720
Dividend Yield	2.51%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review ↗

Today 9:57 EST

The FDA has now accepted the biologics license application for review, setting a Prescription Drug User Fee Act goal date of Aug. 5, 2026.

Via Stocktwits

Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance ↗

April 07, 2025

Qiagen (QGEN) shares up premarket after disclosing strong preliminary Q1 2025 results and raising full-year EPS outlook. Stock price up 3.06%.

Via Benzinga

Performance

YTD	+3.0%	+3.0%
1 Month	-2.8%	-2.8%
3 Month	+9.3%	+9.3%
6 Month	+29.0%	+29.0%
1 Year	+17.5%	+17.5%

More News

3 Gene Editing Stocks with Potential to Transform Medicine ↗

August 09, 2024

Via InvestorPlace

The 3 Best Gene Editing Stocks to Buy in July 2024 ↗

July 08, 2024

Via InvestorPlace

ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play? ↗

June 04, 2021

Via Talk Markets

Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life ↗

May 10, 2024

Via InvestorPlace

3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗

May 02, 2024

Via InvestorPlace

3 Stocks That Could Be the Next Big Thing in Gene Editing ↗

March 21, 2024

Via InvestorPlace

3 Gene Editing Stocks With Unprecedented Surge Potential ↗

February 13, 2024

Via InvestorPlace

3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential ↗

January 31, 2024

Via InvestorPlace

3 Gene Editing Stocks to Generate Super-Charged Gains ↗

October 18, 2023

Via InvestorPlace

The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket ↗

March 25, 2023

Via InvestorPlace

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗

March 15, 2023

Via InvestorPlace

3 Gene Editing Stocks With the Best Long-Term Potential ↗

January 25, 2023

Via InvestorPlace

3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years ↗

January 18, 2023

Via InvestorPlace

ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM ↗

October 21, 2021

Via Talk Markets

A Comprehensive Guide To Genomic ETFs ↗

July 11, 2021

Via Talk Markets

Top-Performing Biotech ETFs of Last Week ↗

June 14, 2021

Via Talk Markets

Frequently Asked Questions

Is Global X Genomics & Biotechnology ETF publicly traded?

Yes, Global X Genomics & Biotechnology ETF is publicly traded.

What exchange does Global X Genomics & Biotechnology ETF trade on?

Global X Genomics & Biotechnology ETF trades on the Nasdaq Stock Market

What is the ticker symbol for Global X Genomics & Biotechnology ETF?

The ticker symbol for Global X Genomics & Biotechnology ETF is GNOM on the Nasdaq Stock Market

What is the current price of Global X Genomics & Biotechnology ETF?

The current price of Global X Genomics & Biotechnology ETF is 47.05

When was Global X Genomics & Biotechnology ETF last traded?

The last trade of Global X Genomics & Biotechnology ETF was at 02/18/26 03:59 PM ET

What is the market capitalization of Global X Genomics & Biotechnology ETF?

The market capitalization of Global X Genomics & Biotechnology ETF is 1.57B

How many shares of Global X Genomics & Biotechnology ETF are outstanding?

Global X Genomics & Biotechnology ETF has 2B shares outstanding.